by PEPID Newsroom | Apr 4, 2019 | Alerts
Kansas-based EHR vendor Cerner proudly takes the industry lead in adopting HL7’s latest rollout – FHIR Release 4, the normative interoperability standard. The vendor embraced FHIR R4 only 3 months after it was published. “It’s incredibly important that...
by PEPID Newsroom | Apr 4, 2019 | Alerts
The FDA is investigating reports of seizures following the use of e-cigarettes, most involving youth and young adult users. The FDA foresees a potential emerging safety issue with the recent voluntary reports of adverse experiences with tobacco products that...
by PEPID Newsroom | Apr 3, 2019 | Alerts
The US FDA approved Cimzia (certolizumab pegol) injection for treatment of adults with non-radiographic axial spondyloarthritis (nr-axSpA), a type of inflammatory arthritis. This is the first fda approved treatment for nr-axSpA. Nr-axSpA causes inflammation in the...
by PEPID Newsroom | Apr 2, 2019 | Alerts
Mayzent (siponimod) The FDA approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Mayzent was shown to be...
by PEPID Newsroom | Apr 1, 2019 | Alerts
Six outbreaks, defined as three or more cases of Measles (Rubeola), are currently ongoing within: New York State, Rockland County New York City Washington California, Santa Cruz County New Jersey California, Butte County There have been 387 confirmed individual cases...
